Similar articles

• The in-vitro activity of cefotetan against Serratia spp. and Enterobacter spp. in comparison with other cephalosporins.

  Campello C, Stradoni R, Majori L. Campello C, et al. J Antimicrob Chemother. 1983 Jan;11 Suppl:87-93. doi: 10.1093/jac/11.suppl_a.87. J Antimicrob Chemother. 1983. PMID: 6573328 No abstract available.
• [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].

  Ronco E, Migueres ML, Vacheron F, Guenounou M. Ronco E, et al. Pathol Biol (Paris). 1988 May;36(5):430-4. Pathol Biol (Paris). 1988. PMID: 3043339 French.
• Antibiotic susceptibility of the Klebsiella-Aerobacter-Serratia group.

  Fekety FR Jr, Partain PJ. Fekety FR Jr, et al. Univ Mich Med Cent J. 1969 Jul-Sep;35(3):155-7. Univ Mich Med Cent J. 1969. PMID: 5384682 No abstract available.
• Some properties of Serratia marcescens, Salmonella paratyphi A, and Enterobacter cloacae with non-enzyme-dependent multiple resistance to beta-lactam antibiotics, aminoglycosides, and quinolones.

  Dang P, Gutmann L, Quentin C, Williamson R, Collatz E. Dang P, et al. Rev Infect Dis. 1988 Jul-Aug;10(4):899-904. doi: 10.1093/clinids/10.4.899. Rev Infect Dis. 1988. PMID: 3055181 Review.
• [Recent data about microorganisms of the genus Serratia (author's transl].

  Marcuccio L, Monno R, Brandonisio O. Marcuccio L, et al. Ann Sclavo. 1978 Jul-Aug;20(4):558-75. Ann Sclavo. 1978. PMID: 380477 Review. Italian.